Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
We work very hard (sometimes biting off more than we can chew as a company) but it is a very rewarding place to work.
Cosa ti piace di più del team di leadership?
Honesty, passion, determination, innovative, hard-working
Qual è la parte migliore del tuo compenso?
stock incentives, salary, bonus, benefits
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
results-oriented, company keeps patients-first, innovative-thinking,
Che cosa ti rende più felice sul posto di lavoro?
Seeing the impact we are having on patients' lives
Other Employee Reviews for Karyopharm Therapeutics
×